Sickle Cell Disease with Dr. Gregory Vercellotti

Journal of Investigative Medicine Podcast

Контент предоставлен BMJ Group. Весь контент подкастов, включая выпуски, графику и описания подкастов, загружается и предоставляется непосредственно BMJ Group или его партнером по платформе подкастов. Если вы считаете, что кто-то использует вашу работу, защищенную авторским правом, без вашего разрешения, вы можете выполнить процедуру, описанную здесь https://ru.player.fm/legal.

1+ y ago 29:09

MP3•Главная эпизода

Архивные серии ("Канал не активен" status)

When? This feed was archived on October 16, 2023 12:08 (6M ago). Last successful fetch was on July 13, 2023 21:21 (9M ago)

Why? Канал не активен status. Нашим серверам не удалось получить доступ к каналу подкаста в течении длительного периода времени.

What now? You might be able to find a more up-to-date version using the search function. This series will no longer be checked for updates. If you believe this to be in error, please check if the publisher's feed link below is valid and contact support to request the feed be restored or if you have any other concerns about this.

In this conversation with Journal of Investigative Medicine Social Media Editor John Dickinson, MD, PhD, University of Nebraska Medical Center, Gregory Vercellotti, MD, from the University of Minnesota provides an overview of the symptoms, diagnosis and management of sickle cell disease. Dr. Vercellotti is a national leader in the field of vascular biology and cares for adult patients with sickle cell disease. This podcast is especially relevant for primary care physicians, hospitalists, ER physicians, and other subspecialists who may not frequently encounter patients with sickle cell disease.

We discuss many of the common features for symptoms, including pain crises, and complications including stroke, pulmonary hypertension, and avascular necrosis. We also discuss some of the social, economic, and racial factors that are often barriers to effective care. Finally, we discuss some of the promising new options including stem cell transplantation and CRISPR-based cures.

34 эпизодов

#Science #BMJ Group #Jim Editor